Unprecedented achievement': who received the first billion COVID vaccinations?
A Randomized Trial Comparing the Safety, Adherence, and Pharmacodynamics Profiles of Two Doses of Sodium Bicarbonate in CKD: the BASE Pilot Trial | American Society of Nephrology
Delaying second COVID-19 vaccine doses can help reduce deaths - study | Reuters
Vaccine schedule based on medical conditions - UpToDate
Inhibition of Complement Factor 3 in Geographic Atrophy with NGM621: Phase 1 Dose-Escalation Study Results - American Journal of Ophthalmology
Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2 | NEJM
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity - ScienceDirect
Hepatitis B Foundation: Hepatitis B Vaccine Schedules
A Single Vaccine Dose Appears To Protect Against COVID-19. So Why Are We Giving Two? | WBUR News
Effectiveness of a third dose of BNT162b2 mRNA COVID-19 vaccine in a large US health system: A retrospective cohort study - The Lancet Regional Health – Americas
Is One Vaccine Dose Enough After COVID-19 Infection? – NIH Director's Blog
Effectiveness of a fourth dose of mRNA COVID-19 vaccine against all-cause mortality in long-term care facility residents and in the oldest old: A nationwide, retrospective cohort study in Sweden - The Lancet
Tinctures — PROOF
2-1-1 PrEP | PrEP-Rx
Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England | Nature Communications
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine | NEJM
Single-Dose COVID-19 Vaccine Gains Endorsement Of CDC Expert Panel : Shots - Health News : NPR
Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021 | MMWR
Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ
Is one-dose COVID-19 vaccination better than two?
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine | NEJM
Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccination | Nature Communications
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials - The Lancet
Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2–experienced individuals | Science Translational Medicine
Are Health Centers Facilitating Equitable Access to COVID-19 Vaccinations? A June 2021 Update. | KFF
Should FDA Reconsider Allowing the Pooling of COVID-19 Vaccine Doses to Obtain Additional Doses? | Institute For Safe Medication Practices
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021 | MMWR
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine - ScienceDirect
